Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Everolimus Versus MMF in Lung Transplant Recipients

Trial Profile

Everolimus Versus MMF in Lung Transplant Recipients

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Apr 2012

At a glance

  • Drugs Everolimus (Primary) ; Mycophenolate mofetil (Primary) ; Ciclosporin; Prednisolone
  • Indications Bronchiolitis obliterans; Lung transplant rejection
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Apr 2012 Primary endpoint results presented at the 32nd Annual Meeting and Scientific Sessions of the International Society for Heart and Lung Transplantation.
    • 21 Apr 2012 Additional descriptors, treatment table details, study initiation and completion dates, patient numbers (updated from 100 to 190) and primary study endpoint added
    • 21 Apr 2012 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top